Target intelligence / Profile preview

Pyruvate dehydrogenase complex, E3-binding protein subunit (PDHX)

Target
PDHX
Molecular classification
Enzyme complex component, Metabolic enzyme complex subunit, Other
01

Overview

Pyruvate dehydrogenase complex, E3-binding protein subunit (PDHX) is a structural component of the mitochondrial pyruvate dehydrogenase complex, essential in cellular respiration. PDHX encodes E3 binding protein, which tethers the E3 (dihydrolipoamide dehydrogenase) enzyme to the E2 core, ensuring proper assembly and function of the PDH complex. The PDH complex catalyzes the conversion of pyruvate to acetyl-CoA, linking glycolysis to the citric acid cycle and ATP production. Mutations in PDHX can cause pyruvate dehydrogenase deficiency, leading to lactic acidosis and severe neurological problems, primarily manifesting in infancy or early childhood. PDHX is also a minor autoantigen in primary biliary cholangitis, contributing to autoimmune destruction of bile duct epithelial cells and subsequent liver dysfunction[1][2][3][6].

Other names
E3 binding proteinPyruvate dehydrogenase protein X component, mitochondrialDihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complexLipoyl-containing pyruvate dehydrogenase complex component XPyruvate dehydrogenase complex, component XPyruvate dehydrogenase complex, lipoyl-containing component XproXOPDXDLDBPPDHXD
02

Mechanism of action

Drugs may target the pyruvate dehydrogenase complex by activating residual enzymatic activity, reducing pyruvate accumulation, or managing lactic acidosis; not directly targeting PDHX but acting downstream or via cofactors[2].

03

Biological functions

Cellular energy metabolismMitochondrial pyruvate oxidationAcetyl-CoA productionLinkage of glycolysis to citric acid cycle
04

Disease associations

Pyruvate dehydrogenase deficiency (metabolic disorder)Neurological dysfunctionLactic acidosisPrimary biliary cholangitis (autoimmune liver disease; minor autoantigen)
05

Safety considerations

Severe lactic acidosis and neurological deficits in loss-of-function or deficiencyTherapeutic challenge in correcting mitochondrial dysfunctionIn autoimmunity (primary biliary cholangitis), risk for progression to cirrhosis and liver failure[1][3]
06

Interacting drugs

None directly targeted by approved drugs; metabolic pathway modulated by agents used off-label such as thiamine and dichloroacetate in pyruvate dehydrogenase deficiency[2].
07

Biomarkers

Serum lactate (elevated in deficiency)Pyruvate levelsGenetic testing for PDHX mutations[2]Presence of anti-mitochondrial antibodies (for primary biliary cholangitis)[1][3]

Beyond the preview

Go deeper on Pyruvate dehydrogenase complex, E3-binding protein subunit (PDHX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyruvate dehydrogenase complex, E3-binding protein subunit (PDHX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call